Transvaginal ultrasound is the only imaging option for diagnosing PCOS

the verdict

REFUTED

the evidence says no

Recorded sources

0 sources for · 3 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Transvaginal ultrasound is not the only imaging or diagnostic option for polycystic ovary syndrome (PCOS), as magnetic resonance imaging and biochemical markers such as anti-Müllerian hormone are also successfully utilized for diagnosis.

The analysis

The claim states that transvaginal ultrasound is the *only* imaging option for diagnosing PCOS. The retrieved literature clearly refutes this exclusivity. Paper [1] demonstrates that magnetic resonance imaging (MRI) can also be used to evaluate antral follicle counts and serve as an alternative to ultrasound. Furthermore, papers [6] and [9] show that biochemical markers like anti-Müllerian hormone (AMH) can replace ultrasound for assessing polycystic ovarian morphology. Therefore, transvaginal ultrasound is neither the exclusive imaging option nor the sole diagnostic modality.

Evidence against · 3

Recorded source metadata

S. Aiyappan, B. Karpagam, V. Vadanika, P. Chidambaram, S. Vinayagam, K. Saravanan. Age-Related Normogram for Ovarian Antral Follicle Count in Women with Polycystic Ovary Syndrome and Comparison with Age Matched Controls Using Magnetic Resonance Imaging.. 2016. https://doi.org/10.7860/JCDR/2016/17334.7136

Paper [1] demonstrates that magnetic resonance imaging (MRI) is an effective alternative to transvaginal ultrasound for evaluating ovarian antral follicle counts in patients with PCOS.

Source citation format

See more details

More against · 2

Diagnosis of Polycystic Ovary Syndrome With Predictive Modeling of Select Clinical Features.

Recorded source metadata

Evans AT, Rehani E, Smith B, Hong MD, Lewin Z, Hiroshige K, Spandorfer SD, Hajirasouliha I, Lujan ME, Hoeger KM. Diagnosis of Polycystic Ovary Syndrome With Predictive Modeling of Select Clinical Features.. 2026. https://doi.org/10.1097/og9.0000000000000161

Paper [6] shows that biochemical markers such as anti-Müllerian hormone (AMH) can predict PCOS diagnosis with high accuracy independently of ultrasound.

Source citation format

Evaluating the PCOS risk algorithm (PriskA): a pilot study.

Recorded source metadata

van der Ham K, Sillman J, Hund M, Mang A, Louwers YV, Laven JSE. Evaluating the PCOS risk algorithm (PriskA): a pilot study.. 2026. https://doi.org/10.1186/s13048-026-02037-6

Paper [9] highlights that blood tests like AMH can replace ultrasound for assessing polycystic ovarian morphology within risk algorithms.

Source citation format

The paper trail · every fact has a biography

first checked02 Aug 2026

judged → REFUTED · 602 Aug 2026

More receipts

Is it true that Phonological evolution involves regular processes of phoneme elision, vowel nasalization, and tonogenesis?Is it true that Hemangiomas are treatable with medication?Is it true that Research identifies forms of intelligence that diverge from standard IQ measures?

Random receipt →The Trust Wiki →

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt